(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Vote in favor of your Favored kind of craftsmanship - 2The most effective method to Recognize a Great Lab Jewel
- 3'Backward and upward and tilted': Spaceflight causes astronauts' brains to shift inside their skulls
- 4Benihana is 60 years old. Gen Z is lining up.
- 5Four countries to boycott Eurovision 2026 over Israel’s inclusion
- 'Stranger Things' star debunks claims of 'unseen footage' from Season 5, Volume 2 as backlash intensifies ahead of the series finale
- Robert Irwin on winning 'Dancing With the Stars' 10 years after sister Bindi: 'This was everything I dreamed it would be and so much more'
- The Solution to Ecological Protection: Saving Nature for People in the future
- Hamas hands over another body in the Gaza Strip
- There’s ‘super flu,’ COVID, RSV. Is it going around in SoCal?
- Polish law aimed at lowering petrol prices takes effect
- Vote in favor of your Number one kind of juice
- Sound Propensities: 20 Methods for helping Your Insusceptible Framework
- Some Americans say they'll go without health insurance as ACA rates spike
